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The derivation, identity, and function of Hodgkin
(H) and Reed-Sternberg (RS) cells of Hodgkin's
Disease (HD) are still an enigma. These cells do not
seem to express specific markers for T or B cell
lineage (Schwab et al., 1982; Poppema et al., 1982)
and the facts which support their derivation from
the monocyte-macrophage series are equally
unconvincing (Poppema et al., 1982; Ford et al.,
1982). A positive identification marker for H and
RS cells, the Ki-I antigen, has been recently
described (Schwab et al., 1982). On the basis of
evidence provided by this marker it has been
suggested that H and RS cells may represent the
malignant counterpart of a unique normal cell type
which does not belong to any known cell lineage.
These cells are identifiable in small numbers around
the lymphoid follicles within normal and reactive
lymph nodes (Schwab et al., 1982). The role played
by H and RS cells in the pathogenetic mechanism
of HD is not known. It is generally assumed,
although not proven, that they might exert a
powerful "destructive" influence leading to
uncontrolled lymphocyte proliferation, depletion, or
nodular sclerosis.
Having this in mind, we investigated, by
immunohistological techniques, the tissue samples
involved by HD with the anti-Tac monoclonal Ab.
The Tac antigen, originally described as a marker
of activated T cells (Uchiyama et al., 1981) and
HTLV positive T leukaemia/lymphoma (Hattory et
al., 1981; Waldmann et al., 1983), has recently been
shown to be the functional receptor for IL-2
(Leonard et al., 1982). The original rationale for
testing the anti-Tac Ab in HD was to investigate
the number and distribution of Tac+ T cells around
the H and RS cells.
The study provided evidence that Tac+ lymphoid
cells are more numerous in HD samples than in
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reactive lymph nodes. Furthermore, an unexpected
finding was that the majority of identifiable H and
RS cells also express the Tac antigen.
Fifteen HD samples were analyzed. These were
from lymph nodes (13 samples), bone marrow and
spleen (one sample each) histologically proven to be
involved by HD. The allocation of samples to the
histological subtypes was lymphocyte predominance
2, nodular sclerosis 8, mixed cellularity 4,
lymphocyte depletion 1. All samples were obtained
at diagnosis, before any treatment was started.
The control samples used were reactive lymph
nodes and selected cases of palatine tonsils removed
after treatment for tonsillitis (7 samples) and
involved spleens in hairy cell leukaemia (2 samples).
The leukaemic hairy cells were used as positive
controls since malignant cells in this disease have
been shown to be Tac+ (Korsmeyer et al., 1983).
Cryostat sections of frozen tissues were used as
described previously (Stein et al., 1980). Briefly,
cryostat sections (6-8 m) were fixed in chloroform-
acetone (1:1) mixture for 5min, air dried and
rehydrated with PBS containing 0.3-1.5mgml-1
IgG Cohon fraction II (to minimize nonspecific Fc
mediated binding) for 20mn. The anti-Tac
antibody (kindly provided by doctors T. Uchiyama
- University of Kyoto, Japan - and T. Waldmann
- NIH, Bethesda USA) was used as ascitic fluid
diluted 1:2000, layered on sections and incubated
for 30min at room temperature. After three brief
washings in PBS, a peroxidase-conjugated rabbit
anti mouse Ig serum (from KPL) was used as
second layer (1:20 dilution, 30min). After a further
washing, peroxidase was made visible by incubating
the sections with diaminobenzidine (0.6mgml-)
and hydrogen peroxide (0.01%) for 10min at room
temperature. After a final wash in PBS, the sections
were mounted for microscopic examination. In
most cases other immunological techniques were
also employed to detect the Tac positivity. These
included immunofluorescence (Pizzolo et al., 1980)
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using a fluorescein conjugated rabbit or goat anti-
mouse Ig second layer, and the Avidin-Biotin-
Peroxidase method (Warnke & Levy, 1980).
Negative controls were performed with irrelevant
non-reactive monoclonal Abs. Immunoperoxidase
stainings were also performed on serial sections in
each case with other monoclonal Abs. These
included T lineage specific reagents, such as RFT1
(OKT1- and Leu-1-like) (Caligaris-Cappio et al.,
1982) and UCHTI (OKT-3-like) (Beverley &
Callard, 1981).
In reactive lymph nodes and tonsils only a few
lymphoid cells (<1%) showed membrane staining
with anti-Tac. These Tac+ cells were more often
found in the paracortical area where the majority of
lymphocytes are of T type. This was demonstrated
on serial sections stained for Tac and for T lineage
specific monoclonal Abs. Leukaemic hairy cells in
the spleen were also Tac+.
In 12/15 HD samples the Tac+ lymphoid cells
were more numerous (5-11%) than in reactive
lymph nodes and tonsils. These cells were present in
areas where the majority of lymphocytes were T
cells, as detected on serial sections. In 2/15 samples
no H or RS cells could be confidently identified on
the immunostained sections. In the remaining 13
samples 50-100% of identifiable H and RS cells (as
judged on Haematoxylin counterstaining serial
sections) exhibited a definite, strong cytoplasmic
reaction with the anti-Tac Ab (Figure 1). In some
cells the Golgi region and the nucleoli also
appeared to be Tac+. The presence of Tac+ H and
RS cells was recorded in cases with different
histology, such as lymphocyte predominance,
nodular sclerosis, lymphocyte depletion or mixed
cellularity.
Our study demonstrates that in tissues involved
by HD Tac+ lymphoid cells are in most cases more
numerous than in reactive lymph nodes and tonsils.
Furthermore, Tac antigen is also strongly expressed
in another cell type which represents a variable but
frequently large proportion of H and RS cells
observed in the sample. The first observation may
be explained with an increased number of activated
or proliferating T cells in HD, since Tac antigen is
expressed on proliferating T cells (Yokoi et al.,
1982) which exhibit membrane receptor for IL-2
(Leonard et al., 1982). The observation of the
presence of Tac antigen on H and RS cells is,
however, intriguing and unexpected. Nevertheless,
Figure 1 Reed-Stemnberg cells (a, b) and Hodgkin cells in lymph nodes infiltrated by Hodgkin's disease
exhibit a strong cytoplasmic staining with the anti-Tac monoclonal antibody. A number of lymphoid looking
cells also express a membrane reactivity. Immunoperoxidase method; no nuclear counterstaining.Tac ANTIGEN IN HODGKIN'S DISEASE 417
the T lineage fidelity of Tac positivity on malignant
cell types has already been questioned. Korsmeyer
et al. (1983) have shown Tac expression on
malignant B cells in hairy cell leukaemia and we
have recently demonstrated the induction of Tac
positivity by phorbolester in a number of different
B cell malignancies, ranging from chronic
lymphocytic leukaemia to prolymphocytic
leukaemia (Caligaris-Cappio et al., submitted). We
have, however, been unsuccessful, using identical
stimulants and conditions, to stimulate the
expression of Tac positivity on the various normal
B cell populations purified from blood and tonsil.
These findings have at least two possible
interpretations. First, anti-Tac may cross-react with
epitopes on molecules other than IL-2 receptor. In
that case the Tac positivity on H and RS cells
could be only a useful identity marker. However,
this possibility may not be the entire answer since
in hairy cell leukaemia the molecular weight of the
recognized Tac+ molecule is identical to that of the
Tac receptor present on the IL-2 responsive cell
lines (Korsmeyer et al., 1983). The more exciting
possibility is therefore that Tac positivity on H and
RS cells, as well as in hairy cell leukaemia and in
other malignant conditions, might be a sign of the
abnormal gene expression which may contribute to
the uncontrolled growth or to the destructive
influence seen in HD.
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